Strategic Partnerships
The Jed Ian Taxel Foundation for Rare Cancer Research partners with leading rare cancer researchers and aligned organizations to empower innovation and accelerate discovery in rare cancer research that translates into lifesaving treatments and better outcomes for rare cancer patients, their families, and the world.
The Jed Ian Taxel Foundation for Rare Cancer Research has formed a strategic partnership with The Herbert Irving Comprehensive Cancer Center (HICCC), home for cancer research and patient care at Columbia University and New York-Presbyterian/Columbia University Irving Medical Center.
Together, we are co-sponsoring the CME Conference “Rare Cancers: Great Unmet Medical Needs” at Columbia University on April 26, 2022. The conference brings together rare cancer experts from around the country to discuss advances in rare cancer research, propose future directions in cancer medicine for rare cancers, and delineate a blueprint for investing resources in the treatment and cure of rare cancers.
HICCC researchers and physicians are dedicated to understanding the complex biology behind cancer – from before it begins to its evolution and spread, then applying that knowledge to the discovery and design of innovative cancer therapies and prevention strategies that reduce the disease’s incidence and progression and improve the quality of life for all those affected.
Dr. Anil K. Rustgi, HICCC Director at NewYork-Presbyterian/Columbia University Irving Medical Center (CUMC) welcomed The Jed Ian Taxel Foundation to the Columbia University family and invited our foundation president Mark Taxel to join the Columbia Memorial Hospital Patient and Family Advisory Council.
Dr. Michael Weiner, The Jed Ian Taxel Foundation Board of Directors and Medical Advisory Board Member and Vice Chair and Hettiger Professor of Columbia Children’s Health at CUMC, initiated our co-sponsorship with Columbia University of the April 26, 2022 CME Conference “Rare Cancers: Great Unmet Medical Needs.”
Dr. Gary Schwartz, Professor of Medicine at CUMC, Columbia University Vagelos College of Physicians and Surgeons is organizing and managing “Rare Cancers: Great Unmet Medical Needs,” the April 26, 2022 CME Conference our foundation is co-sponsoring with Columbia University.
Dr. Jordon Orange, The Jed Ian Taxel Foundation Medical Advisory Board Member and Reuben S. Carpentier Professor and Chair Department of Pediatrics, Vagelos College of Physicians and Surgeons Columbia University Physician In-Chief, Morgan Stanley Children’s Hospital New-York Presbyterian, shared these words at our fundraiser: “I am inspired to see the strength and power of the people in this room. I’ve had the privilege of meeting an extraordinary community and this is the group that can make the difference.”
The Jed Ian Taxel Foundation for Rare Cancer Research is fielding a national team JEDIs for Survival to raise funds for Cycle for Survival 2022, an annual fundraiser that supports rare cancer research at Memorial Sloan Kettering Cancer Center (MSK), which owns and operates Cycle for Survival. Since 2007, they have raised over 280 million dollars for their rare cancer research programs.
Our foundation is matching the first $10,000 raised by each of our regional teams with a total national team goal of $160,000 raised to support MSK’s 2022 rare cancer research programs. Our Medical Advisory Board will direct the funding to an MSK research program or programs that align closely with our rare cancer strategic priorities.
WE RIDE TO HELP DEFEAT RARE CANCERS.